US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Hua Medicine (PK) (HUMDF) 銘柄情報

Hua Medicine (PK) (HUMDF)

0.3401

0.00

( 0.00% )

更新日時： 22:42:06

Hua Medicine (PK) (HUMDF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.3401

( - )

買値

0.2986

売値

0.3786

出来高

-

平均取引量 (3 か月)

US$ 3,193,617

財務取引量

-

0.00 日の範囲 0.00

0.3399 52 週間の範囲 0.50

時価総額

企業価値

1.426B

前日終値

0.3401

始値

-

時刻

最終取引時間

-

VWAP

-

歳入

492.93M

純利益

1.11B

発行済株式数

996,519,632

浮動株比率 (%)

66.36%

機関投資家保有比率 (%)

29.70%

配当利回り

PER

2.02

株価売上高倍率 (PSR)

4.5

1 株当たり利益 (EPS)

1.1

ベータ

0.8

Hua Medicine (Shanghai) Ltd. engages in the development and commercialization of drugs for the treatment of diabetes in China. The company develops HuaTangNing (Dorzagliatin or HMS5552), an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitaglip... Hua Medicine (Shanghai) Ltd. engages in the development and commercialization of drugs for the treatment of diabetes in China. The company develops HuaTangNing (Dorzagliatin or HMS5552), an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D and DKD. It also provides Dorzagliatin in combination with GLP1RA and small molecule GLP-1 for T2D and obesity; combination with insulin to treat insulin sparing in T2D; second generation glucokinase (GK) inhibitor and GK NAM for metabolic disease; mGLUR5 negative allosteric modulator (NAM) for PD-LID and drug addiction; and Dorzagliatin for the treatment of T2D-Drug Naïve, T2D-Metformin Tolerated, RWE study for Diabetes Remission, MODY-2, Diabetes prevention IGT2NGT, Frailty, Early AD, and CFRD. Hua Medicine (Shanghai) Ltd. was incorporated in 2011 and is headquartered in Shanghai, China. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.huamedicine.com

本社

Shanghai, China

設立

2026

Hua Medicine (PK) is listed in the Healthcare sector of the その他OTC with ticker HUMDF. The last closing price for Hua Medicine (PK) was US$0.34. Over the last year, Hua Medicine (PK) shares have traded in a share price range of US$ 0.3399 to US$ 0.50.

Hua Medicine (PK) currently has 996,519,632 shares in issue. The market capitalisation of Hua Medicine (PK) is US$338.92 million. Hua Medicine (PK) has a price to earnings ratio (PE ratio) of 2.02.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	-0.1321	-27.9754341381	0.4722	0.4722	0.3399	4000	0.38625	CS
26	-0.0706	-17.1901631361	0.4107	0.5	0.3399	7970	0.44680834	CS
52	-0.0706	-17.1901631361	0.4107	0.5	0.3399	3261	0.44680834	CS
156	0.1373	67.7021696252	0.2028	0.5	0.15	2561	0.42744618	CS
260	-0.2373	-41.0980256321	0.5774	0.7	0.15	3897	0.48264154	CS

HUMDF - Frequently Asked Questions (FAQ)

What is the current Hua Medicine (PK) share price?

The current share price of Hua Medicine (PK) is US$ 0.3401

How many Hua Medicine (PK) shares are in issue?

Hua Medicine (PK) has 996,519,632 shares in issue

What is the market cap of Hua Medicine (PK)?

The market capitalisation of Hua Medicine (PK) is USD 338.92M

What is the 1 year trading range for Hua Medicine (PK) share price?

Hua Medicine (PK) has traded in the range of US$ 0.3399 to US$ 0.50 during the past year

What is the PE ratio of Hua Medicine (PK)?

The price to earnings ratio of Hua Medicine (PK) is 2.02

What is the cash to sales ratio of Hua Medicine (PK)?

The cash to sales ratio of Hua Medicine (PK) is 4.5

What is the registered address of Hua Medicine (PK)?

The registered address for Hua Medicine (PK) is Hua Medicine, Building 2, Lane 36, Shanghai, 201203

What is the Hua Medicine (PK) website address?

The website address for Hua Medicine (PK) is www.huamedicine.com

Which industry sector does Hua Medicine (PK) operate in?

Hua Medicine (PK) operates in the Pharmaceuticals sector

Chartmaster

Chartmaster 5分前

bought 10 SNDK at 1818 today

surfkast

surfkast 5分前

Hey. Did they pull the old man and his wheelchair out of the cave yet? 🤣

Chartmaster

Chartmaster 5分前

bought 10 at 1818 today

surfkast

surfkast 5分前

Another red day with insiders dumpiong?

CatfishHunter

CatfishHunter 6分前

I agree. And in my opinion, the big game changer will be the initial EFS results. New investors, especially the hostage investors in my opinion, are waiting for proof of concept from a reputable institution, and that will be Mayo Clinic. The EFS can start as early as August more likely September and

BottomBounce

BottomBounce 6分前

$PLUG buying hand over fist.,. doubling down for $3 instead of $5

vlispxpert

vlispxpert 6分前

PLUG zone under $1.75, I'll be big buyer there thanks

BaldEagle26

BaldEagle26 6分前

Doesn't appear to be iceberg sell order at .0023. Seems as though there is no dilution today

vlispxpert

vlispxpert 7分前

XE big shakedown on higher than norm volumes, keep loading dips...acting like final shakedown to me imo

stockhero

stockhero 7分前

Going between 6 7. 💁‍♀️💁

BottomBounce

BottomBounce 7分前

Plug Power $PLUG reported $163.5 million in Q1 2026 revenue, marking a 22% year-over-year increase and improved gross margins.

BottomBounce

BottomBounce 8分前

Plug Power $PLUG reported $163.5 million in Q1 2026 revenue, marking a 22% year-over-year increase and improved gross margins.

Mark

$VSEE .11 bottom chart

hankmanhub

hankmanhub 8分前

Promotional behavior does not prevent dilution.
"Pevent" mat be too strong a word, but "reduces" would be right on the mark.
The supporters’ point isn’t that silence magically prevents dilution.
I think you meant "promotion" and not "silence."

Ron Burgandy79

Ron Burgandy79 8分前

My 10,000 dollar investment here is now worth $63 dollars. Rick Jordan is a horrible person who deserves to be locked up for fraud. Can’t wait to meet him face to face and discuss his actions!

mick

GOLD LGCXF INTERESTING

The Truth Hurts

The Truth Hurts 8分前

Nah, thats not how i trade bud.

glenn1919

glenn1919 8分前

ZBAO.....DFNS.....JZXN.....https://stockcharts.com/sc3/ui/?s=ZBAO&p=w&yr=1&mn=3&dy=0&id=p96837884856

FOFreddie

FOFreddie 9分前

ROLG is out with new Post on Fairholme DC Circuit Court of Appeals Decision. July 21 will be 90 days since Hearing

https://x.com/rule_of_law_guy/status/2075558794445111482

Dyesir2025

Dyesir2025 9分前

Same thing happening in FMCC for 550 shares. The 3,333 in FANM seemed to
be accompanied with a second 3,333 and a 3,334 to come up with 10,000 shares.
My hope is that someone knows that Am Funds is getting close to an end

Monksdream

Monksdream 10分前

NVVE, in the Top 15
https://www.advfn.com/markets/nasdaq/premarket

BottomBounce

BottomBounce 10分前

🔥 The $2.3 Trillion Organic Food Supercycle: 10 Reasons Beyond Meat $BYND Could Be a Major Winner
https://x.com/BakkenShale/status/2061534666205843796

BottomBounce

BottomBounce 10分前

🔥 The $2.3 Trillion Organic Food Supercycle: 10 Reasons Beyond Meat $BYND Could Be a Major Winner
https://x.com/BakkenShale/status/2061534666205843796

iHub News

iHub News 11分前

U.S. Futures Drift as Investors Await Earnings Season and Inflation Data: Dow Jones, S&P, NasdaqJuly 10, 2026 9:31 AM
IH Market News

Hua Medicine (PK)

Btg Pactual Logistica Fd...

State Street SPDR Bloomb...

ECN Capital (PK)

Bmo Harris Bank Na Cappe...

Betapro S&P TSX Capped F... (EM)

State Street SPDR S&P US...

Ford Motor Credit

iShares USD Treasury Bon...

Legal & General Ucits Etf

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。